IP Library › Granted Patent US 10,593,487
Granted Patent B2
US 10,593,487 · App. 15/509,990 · Granted Mar 17, 2020

Mixed organic-inorganic perovskite formulations

Inventors: Nicola Beaumont (Oxford, GB); Brett Akira Kamino (Oxford, GB); Benjamin Langley (Oxford, GB); Edward James William Crossland (Oxford, GB)
Assignee: OXFORD PHOTOVOLTAICS LIMITED
H01G9/2009C01G21/006C07C251/30H01G9/2031H01L31/032H01L51/0032H01L51/0077H01L51/4226C01P2002/34C01P2002/72C01P2006/90H01L2031/0344Y02E10/549Y02P70/521
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,593,487
App. No.
15/509,990
Granted
Mar 17, 2020
Kind
B2
Abstract

A formulation for use in the preferential formation of thin films of a perovskite material AMX 3 with a certain required crystalline structure, wherein said formulation comprises two or more compounds which between them comprise one or more first organic cations A; one or more metalcations M; one or more second cations A′; one or more first anions X and one or more second anions X′.

Claims (39)

1. A formulation for use in the formation of a light absorbing perovskite material having a general formula (I) of:

AMX 3   (I)

wherein A is one or more monovalent cations, M is one or more divalent metal cations, and X is one or more halide anions, the formulation comprising two or more compounds which between them comprise:

the one or more monovalent cations A;

the one or more divalent metal cations M;

the one or more halide anions X;

one or more further monovalent cations A′; and

one or more further halide anions X′;

wherein the one or more further monovalent cations A′ and the one or more further halide anions X′ are selected to form one or more A′X′-containing compounds which are able to be fully separated from the AMX 3 material at a temperature of less than 200° C.

2. A formulation according to claim 1 , wherein the perovskite material is black in colour.

3. A formulation according to claim 1 , wherein the perovskite material has a band gap below 3.0 eV.

4. A formulation according to claim 1 , wherein the formulation comprises an excess of the one or more further monovalent cations A′ and the one or more further halide anions X′.

5. A formulation according to claim 4 , wherein the ratio of the one or more further monovalent cations A′ and the one or more further halide anions X′ to the one or more monovalent cations A and the one or more halide anions X is from 1.6:1 to 2.1:1.

6. A formulation according to claim 1 , wherein A is one or two monovalent cations, M is a divalent metal cation, and X is one or more halide anions, and the formulation comprises two or more compounds which between them comprise:

the one or two monovalent cations A;

the divalent metal cation M;

the one or more halide anions X;

a further monovalent cation A′; and

a further halide anion X′.

7. A formulation according to claim 1 , wherein A comprises a first monovalent cation and the formulation comprises:

a first precursor compound comprising the first monovalent cation A and a halide anion X;

a second precursor compound comprising a further monovalent cation A′ and a halide anion X; and

a third precursor compound comprising a metal cation M and a further halide anion X′.

8. A formulation according to claim 1 , wherein A comprises a first monovalent cation Ai, and a second monovalent cation A 2 , and the formulation comprises:

a first precursor compound comprising the first monovalent cation A 1 and a halide anion X;

a second precursor compound comprising a further monovalent cation A′ and a halide anion X;

a third precursor compound comprising the second monovalent cation A 2 and a halide anion X; and

a fourth precursor compound comprising a metal cation M, and a further halide anion X′.

9. A formulation according to claim 1 , wherein at least one of the one or more monovalent cations A, and the one or more further monovalent cations A′, are selected from ammonium (NH 4 + ), methyl ammonium (CH 3 NH 3 + ), formamidinium (HC(NH 2 ) 2 + ), methylformamidinium (H 3 CC(NH) 2 ) 2 + ), guanidinium (C(NH) 2 ) 3 + ), tetramethylammonium ((CH 3 ) 4 N + ), dimethylammonium ((CH 3 ) 2 NH 2 + ) and trimethylammonium ((CH 3 ) 3 NH + ), Cs + Rb + , Cu + , Pd + , Pt + , Ag + , Au + , Rh + , and Ru + .

10. A formulation according to claim 1 , wherein A comprises any of:

methyl ammonium (CH 3 NH 3 + ) and formamidinium (HC(NH 2 ) 2 + );

formamidinium (HC(NH 2 ) 2 + ) and Cs + ; and

formamidinium (HC(NH 2 ) 2 + ).

11. A formulation according to claim 10 , wherein A′ comprises one or more of ammonium (NH 4 + ) and methyl ammonium (CH 3 NH 3 + ).

12. A formulation according to claim 1 , wherein M comprises one or more of Pb 2+ , Sn 2+ , and Bi 2+ .

13. A formulation according to claim 1 , wherein X comprises one or more halide anions selected from fluoride, chloride, bromide, and iodide.

14. A formulation according to claim 1 , wherein X′ comprises one or more halide anions selected from fluoride, chloride, bromide, and iodide.

15. A precursor solution for use to make a perovskite material of the general formula AMX 3 , said precursor solution comprising a suitable solvent system and two or more compounds which between them comprise one or more first cations A; one or more metal cations, M; one or more second cations A′; one or more first anions X and one or more second anions X′; and further wherein the ratio of ions is selected such that A:M:X is 1:1:3, and the amount of and choice of the one or more second cations A′ and second anions X′ is selected to form one or more A′X′-containing compounds which are able to be fully separated from the AMX 3 material at a temperature of less than 200° C.

16. A precursor solution according to claim 15 , and comprising a solvent system comprising one or more solvents selected from dimethyl sulfoxide (DMSO), N,N-dimethylformamide (DMF), N-cyclohexyl-2-pyrrolidone (CHP), and dimethylacetamide (DMAc).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2017
From: BEAUMONT, NICOLA; KAMINO, BRETT AKIRA; LANGLEY, BENJAMIN; CROSSLAND, EDWARD JAMES WILLIAM
To: OXFORD PHOTOVOLTAICS LIMITED
Reel/Frame 043935/0378 →
Priority Claims (1)
GB 1416042.8 · Sep 10, 2014 · national
Continuity (1)
Related Publication 20170243699A1 · Aug 24, 2017
Cited By (1)
US 12,274,109